Literature DB >> 26933753

Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.

Frederick E Dewey1, Viktoria Gusarova1, Colm O'Dushlaine1, Omri Gottesman1, Jesus Trejos1, Charleen Hunt1, Cristopher V Van Hout1, Lukas Habegger1, David Buckler1, Ka-Man V Lai1, Joseph B Leader1, Michael F Murray1, Marylyn D Ritchie1, H Lester Kirchner1, David H Ledbetter1, John Penn1, Alexander Lopez1, Ingrid B Borecki1, John D Overton1, Jeffrey G Reid1, David J Carey1, Andrew J Murphy1, George D Yancopoulos1, Aris Baras1, Jesper Gromada1, Alan R Shuldiner1.   

Abstract

BACKGROUND: Higher-than-normal levels of circulating triglycerides are a risk factor for ischemic cardiovascular disease. Activation of lipoprotein lipase, an enzyme that is inhibited by angiopoietin-like 4 (ANGPTL4), has been shown to reduce levels of circulating triglycerides.
METHODS: We sequenced the exons of ANGPTL4 in samples obtain from 42,930 participants of predominantly European ancestry in the DiscovEHR human genetics study. We performed tests of association between lipid levels and the missense E40K variant (which has been associated with reduced plasma triglyceride levels) and other inactivating mutations. We then tested for associations between coronary artery disease and the E40K variant and other inactivating mutations in 10,552 participants with coronary artery disease and 29,223 controls. We also tested the effect of a human monoclonal antibody against ANGPTL4 on lipid levels in mice and monkeys.
RESULTS: We identified 1661 heterozygotes and 17 homozygotes for the E40K variant and 75 participants who had 13 other monoallelic inactivating mutations in ANGPTL4. The levels of triglycerides were 13% lower and the levels of high-density lipoprotein (HDL) cholesterol were 7% higher among carriers of the E40K variant than among noncarriers. Carriers of the E40K variant were also significantly less likely than noncarriers to have coronary artery disease (odds ratio, 0.81; 95% confidence interval, 0.70 to 0.92; P=0.002). K40 homozygotes had markedly lower levels of triglycerides and higher levels of HDL cholesterol than did heterozygotes. Carriers of other inactivating mutations also had lower triglyceride levels and higher HDL cholesterol levels and were less likely to have coronary artery disease than were noncarriers. Monoclonal antibody inhibition of Angptl4 in mice and monkeys reduced triglyceride levels.
CONCLUSIONS: Carriers of E40K and other inactivating mutations in ANGPTL4 had lower levels of triglycerides and a lower risk of coronary artery disease than did noncarriers. The inhibition of Angptl4 in mice and monkeys also resulted in corresponding reductions in these values. (Funded by Regeneron Pharmaceuticals.).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26933753      PMCID: PMC4900689          DOI: 10.1056/NEJMoa1510926

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  40 in total

1.  A solution to the problem of separation in logistic regression.

Authors:  Georg Heinze; Michael Schemper
Journal:  Stat Med       Date:  2002-08-30       Impact factor: 2.373

2.  From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline.

Authors:  Geraldine A Van der Auwera; Mauricio O Carneiro; Christopher Hartl; Ryan Poplin; Guillermo Del Angel; Ami Levy-Moonshine; Tadeusz Jordan; Khalid Shakir; David Roazen; Joel Thibault; Eric Banks; Kiran V Garimella; David Altshuler; Stacey Gabriel; Mark A DePristo
Journal:  Curr Protoc Bioinformatics       Date:  2013

3.  ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys.

Authors:  Viktoria Gusarova; Corey A Alexa; Yan Wang; Ashique Rafique; Jee Hae Kim; David Buckler; Ivory J Mintah; Lisa M Shihanian; Jonathan C Cohen; Helen H Hobbs; Yurong Xin; David M Valenzuela; Andrew J Murphy; George D Yancopoulos; Jesper Gromada
Journal:  J Lipid Res       Date:  2015-05-11       Impact factor: 5.922

4.  Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages.

Authors:  Laeticia Lichtenstein; Frits Mattijssen; Nicole J de Wit; Anastasia Georgiadi; Guido J Hooiveld; Roelof van der Meer; Yin He; Ling Qi; Anja Köster; Jouke T Tamsma; Nguan Soon Tan; Michael Müller; Sander Kersten
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

5.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.

Authors:  Stefano Romeo; Len A Pennacchio; Yunxin Fu; Eric Boerwinkle; Anne Tybjaerg-Hansen; Helen H Hobbs; Jonathan C Cohen
Journal:  Nat Genet       Date:  2007-02-25       Impact factor: 38.330

6.  Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.

Authors:  Stefano Romeo; Wu Yin; Julia Kozlitina; Len A Pennacchio; Eric Boerwinkle; Helen H Hobbs; Jonathan C Cohen
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

7.  Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis.

Authors:  Hironori Adachi; Yukio Fujiwara; Tatsuya Kondo; Takeshi Nishikawa; Rei Ogawa; Takeshi Matsumura; Norio Ishii; Ryoji Nagai; Keishi Miyata; Mitsuhisa Tabata; Hiroyuki Motoshima; Noboru Furukawa; Kaku Tsuruzoe; Junji Kawashima; Motohiro Takeya; Shizuya Yamashita; Gou Young Koh; Andras Nagy; Toshio Suda; Yuichi Oike; Eiichi Araki
Journal:  Biochem Biophys Res Commun       Date:  2008-12-16       Impact factor: 3.575

8.  Variation in ANGPTL4 and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.

Authors:  Aaron R Folsom; James M Peacock; Ellen Demerath; Eric Boerwinkle
Journal:  Metabolism       Date:  2008-11       Impact factor: 8.694

9.  Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks.

Authors:  Gina M Peloso; Paul L Auer; Joshua C Bis; Arend Voorman; Alanna C Morrison; Nathan O Stitziel; Jennifer A Brody; Sumeet A Khetarpal; Jacy R Crosby; Myriam Fornage; Aaron Isaacs; Johanna Jakobsdottir; Mary F Feitosa; Gail Davies; Jennifer E Huffman; Ani Manichaikul; Brian Davis; Kurt Lohman; Aron Y Joon; Albert V Smith; Megan L Grove; Paolo Zanoni; Valeska Redon; Serkalem Demissie; Kim Lawson; Ulrike Peters; Christopher Carlson; Rebecca D Jackson; Kelli K Ryckman; Rachel H Mackey; Jennifer G Robinson; David S Siscovick; Pamela J Schreiner; Josyf C Mychaleckyj; James S Pankow; Albert Hofman; Andre G Uitterlinden; Tamara B Harris; Kent D Taylor; Jeanette M Stafford; Lindsay M Reynolds; Riccardo E Marioni; Abbas Dehghan; Oscar H Franco; Aniruddh P Patel; Yingchang Lu; George Hindy; Omri Gottesman; Erwin P Bottinger; Olle Melander; Marju Orho-Melander; Ruth J F Loos; Stefano Duga; Piera Angelica Merlini; Martin Farrall; Anuj Goel; Rosanna Asselta; Domenico Girelli; Nicola Martinelli; Svati H Shah; William E Kraus; Mingyao Li; Daniel J Rader; Muredach P Reilly; Ruth McPherson; Hugh Watkins; Diego Ardissino; Qunyuan Zhang; Judy Wang; Michael Y Tsai; Herman A Taylor; Adolfo Correa; Michael E Griswold; Leslie A Lange; John M Starr; Igor Rudan; Gudny Eiriksdottir; Lenore J Launer; Jose M Ordovas; Daniel Levy; Y-D Ida Chen; Alexander P Reiner; Caroline Hayward; Ozren Polasek; Ian J Deary; Ingrid B Borecki; Yongmei Liu; Vilmundur Gudnason; James G Wilson; Cornelia M van Duijn; Charles Kooperberg; Stephen S Rich; Bruce M Psaty; Jerome I Rotter; Christopher J O'Donnell; Kenneth Rice; Eric Boerwinkle; Sekar Kathiresan; L Adrienne Cupples
Journal:  Am J Hum Genet       Date:  2014-02-06       Impact factor: 11.025

10.  Common variants associated with plasma triglycerides and risk for coronary artery disease.

Authors:  Ron Do; Cristen J Willer; Ellen M Schmidt; Sebanti Sengupta; Chi Gao; Gina M Peloso; Stefan Gustafsson; Stavroula Kanoni; Andrea Ganna; Jin Chen; Martin L Buchkovich; Samia Mora; Jacques S Beckmann; Jennifer L Bragg-Gresham; Hsing-Yi Chang; Ayşe Demirkan; Heleen M Den Hertog; Louise A Donnelly; Georg B Ehret; Tõnu Esko; Mary F Feitosa; Teresa Ferreira; Krista Fischer; Pierre Fontanillas; Ross M Fraser; Daniel F Freitag; Deepti Gurdasani; Kauko Heikkilä; Elina Hyppönen; Aaron Isaacs; Anne U Jackson; Asa Johansson; Toby Johnson; Marika Kaakinen; Johannes Kettunen; Marcus E Kleber; Xiaohui Li; Jian'an Luan; Leo-Pekka Lyytikäinen; Patrik K E Magnusson; Massimo Mangino; Evelin Mihailov; May E Montasser; Martina Müller-Nurasyid; Ilja M Nolte; Jeffrey R O'Connell; Cameron D Palmer; Markus Perola; Ann-Kristin Petersen; Serena Sanna; Richa Saxena; Susan K Service; Sonia Shah; Dmitry Shungin; Carlo Sidore; Ci Song; Rona J Strawbridge; Ida Surakka; Toshiko Tanaka; Tanya M Teslovich; Gudmar Thorleifsson; Evita G Van den Herik; Benjamin F Voight; Kelly A Volcik; Lindsay L Waite; Andrew Wong; Ying Wu; Weihua Zhang; Devin Absher; Gershim Asiki; Inês Barroso; Latonya F Been; Jennifer L Bolton; Lori L Bonnycastle; Paolo Brambilla; Mary S Burnett; Giancarlo Cesana; Maria Dimitriou; Alex S F Doney; Angela Döring; Paul Elliott; Stephen E Epstein; Gudmundur Ingi Eyjolfsson; Bruna Gigante; Mark O Goodarzi; Harald Grallert; Martha L Gravito; Christopher J Groves; Göran Hallmans; Anna-Liisa Hartikainen; Caroline Hayward; Dena Hernandez; Andrew A Hicks; Hilma Holm; Yi-Jen Hung; Thomas Illig; Michelle R Jones; Pontiano Kaleebu; John J P Kastelein; Kay-Tee Khaw; Eric Kim; Norman Klopp; Pirjo Komulainen; Meena Kumari; Claudia Langenberg; Terho Lehtimäki; Shih-Yi Lin; Jaana Lindström; Ruth J F Loos; François Mach; Wendy L McArdle; Christa Meisinger; Braxton D Mitchell; Gabrielle Müller; Ramaiah Nagaraja; Narisu Narisu; Tuomo V M Nieminen; Rebecca N Nsubuga; Isleifur Olafsson; Ken K Ong; Aarno Palotie; Theodore Papamarkou; Cristina Pomilla; Anneli Pouta; Daniel J Rader; Muredach P Reilly; Paul M Ridker; Fernando Rivadeneira; Igor Rudan; Aimo Ruokonen; Nilesh Samani; Hubert Scharnagl; Janet Seeley; Kaisa Silander; Alena Stančáková; Kathleen Stirrups; Amy J Swift; Laurence Tiret; Andre G Uitterlinden; L Joost van Pelt; Sailaja Vedantam; Nicholas Wainwright; Cisca Wijmenga; Sarah H Wild; Gonneke Willemsen; Tom Wilsgaard; James F Wilson; Elizabeth H Young; Jing Hua Zhao; Linda S Adair; Dominique Arveiler; Themistocles L Assimes; Stefania Bandinelli; Franklyn Bennett; Murielle Bochud; Bernhard O Boehm; Dorret I Boomsma; Ingrid B Borecki; Stefan R Bornstein; Pascal Bovet; Michel Burnier; Harry Campbell; Aravinda Chakravarti; John C Chambers; Yii-Der Ida Chen; Francis S Collins; Richard S Cooper; John Danesh; George Dedoussis; Ulf de Faire; Alan B Feranil; Jean Ferrières; Luigi Ferrucci; Nelson B Freimer; Christian Gieger; Leif C Groop; Vilmundur Gudnason; Ulf Gyllensten; Anders Hamsten; Tamara B Harris; Aroon Hingorani; Joel N Hirschhorn; Albert Hofman; G Kees Hovingh; Chao Agnes Hsiung; Steve E Humphries; Steven C Hunt; Kristian Hveem; Carlos Iribarren; Marjo-Riitta Järvelin; Antti Jula; Mika Kähönen; Jaakko Kaprio; Antero Kesäniemi; Mika Kivimaki; Jaspal S Kooner; Peter J Koudstaal; Ronald M Krauss; Diana Kuh; Johanna Kuusisto; Kirsten O Kyvik; Markku Laakso; Timo A Lakka; Lars Lind; Cecilia M Lindgren; Nicholas G Martin; Winfried März; Mark I McCarthy; Colin A McKenzie; Pierre Meneton; Andres Metspalu; Leena Moilanen; Andrew D Morris; Patricia B Munroe; Inger Njølstad; Nancy L Pedersen; Chris Power; Peter P Pramstaller; Jackie F Price; Bruce M Psaty; Thomas Quertermous; Rainer Rauramaa; Danish Saleheen; Veikko Salomaa; Dharambir K Sanghera; Jouko Saramies; Peter E H Schwarz; Wayne H-H Sheu; Alan R Shuldiner; Agneta Siegbahn; Tim D Spector; Kari Stefansson; David P Strachan; Bamidele O Tayo; Elena Tremoli; Jaakko Tuomilehto; Matti Uusitupa; Cornelia M van Duijn; Peter Vollenweider; Lars Wallentin; Nicholas J Wareham; John B Whitfield; Bruce H R Wolffenbuttel; David Altshuler; Jose M Ordovas; Eric Boerwinkle; Colin N A Palmer; Unnur Thorsteinsdottir; Daniel I Chasman; Jerome I Rotter; Paul W Franks; Samuli Ripatti; L Adrienne Cupples; Manjinder S Sandhu; Stephen S Rich; Michael Boehnke; Panos Deloukas; Karen L Mohlke; Erik Ingelsson; Goncalo R Abecasis; Mark J Daly; Benjamin M Neale; Sekar Kathiresan
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

View more
  169 in total

1.  The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding.

Authors:  Katrine Z Leth-Espensen; Kristian K Kristensen; Anni Kumari; Anne-Marie L Winther; Stephen G Young; Thomas J D Jørgensen; Michael Ploug
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 11.205

2.  To absorb fat - supersize my lipid droplets.

Authors:  Ira J Goldberg; M Mahmood Hussain
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

3.  Novel GPIHBP1-independent pathway for clearance of plasma TGs in Angptl4-/-Gpihbp1-/- mice.

Authors:  Emily M Cushing; Kelli L Sylvers; Xun Chi; Shwetha K Shetty; Brandon S J Davies
Journal:  J Lipid Res       Date:  2018-05-08       Impact factor: 5.922

Review 4.  ANGPTL4 in Metabolic and Cardiovascular Disease.

Authors:  Binod Aryal; Nathan L Price; Yajaira Suarez; Carlos Fernández-Hernando
Journal:  Trends Mol Med       Date:  2019-06-21       Impact factor: 11.951

5.  Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition.

Authors:  Haruka Okamoto; Katie Cavino; Erqian Na; Elizabeth Krumm; Steven Kim; Panayiotis E Stevis; Joyce Harp; Andrew J Murphy; George D Yancopoulos; Jesper Gromada
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

6.  Genomic Risk Stratification Predicts All-Cause Mortality After Cardiac Catheterization.

Authors:  Michael G Levin; Rachel L Kember; Renae Judy; David Birtwell; Heather Williams; Zolt Arany; Jay Giri; Marie Guerraty; Tom Cappola; Jinbo Chen; Daniel J Rader; Scott M Damrauer
Journal:  Circ Genom Precis Med       Date:  2018-11

Review 7.  Drug development in the era of precision medicine.

Authors:  Sarah A Dugger; Adam Platt; David B Goldstein
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

Review 8.  Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.

Authors:  Michael V Holmes; Mika Ala-Korpela; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2017-06-01       Impact factor: 32.419

9.  Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition.

Authors:  Debapriya Basu; Lesley-Ann Huggins; Diego Scerbo; Joseph Obunike; Adam E Mullick; Paul L Rothenberg; Nicholas A Di Prospero; Robert H Eckel; Ira J Goldberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

10.  Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema.

Authors:  Akrit Sodhi; Tao Ma; Deepak Menon; Monika Deshpande; Kathleen Jee; Aumreetam Dinabandhu; Jordan Vancel; Daoyuan Lu; Silvia Montaner
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.